Stocks
Edwards Lifesciences (EW) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -0.66 | -0.41 | -0.29 | -0.27 | -0.54 | -2.36 | |||
| Changes by years, y/y, % | +3% | -38% | -28% | -9% | +101% | +15.5% | |||
Edwards Lifesciences. Debt/EBITDA
Edwards Lifesciences. Debt/EBITDA, changes, %
Edwards Lifesciences (EW) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | -0.57 | -0.53 | -0.77 | -0.75 | -2.23 | -2.36 | ||
| Changes by years, y/y, % | +88% | +74% | +86% | +82% | +271% | |||
| Changes by quarters, q/q, % | +18% | -7% | +45% | -2% | +197% | |||
